Marilyn Delacruz

Title: The Innovations of Marilyn Delacruz

Introduction

Marilyn Delacruz is a prominent inventor based in Matawan, NJ (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds for the treatment of conditions associated with DGAT1 activity. With a total of 2 patents to her name, her work is paving the way for advancements in medical treatments.

Latest Patents

Delacruz's latest patents focus on novel crystalline forms of salts of 2-((1R,4R)-4-(4-(5-(benzo[d]oxazol-2-ylamino)pyridin-2-yl)phenyl)cyclohexyl)acetic acid. These inventions are aimed at the treatment or prevention of conditions or disorders associated with DGAT1 activity in animals, particularly humans. Her innovative approach is expected to have a significant impact on therapeutic options available for various health conditions.

Career Highlights

Marilyn Delacruz is currently associated with Novartis AG, a leading global healthcare company. Her role at Novartis allows her to collaborate with other experts in the field and contribute to groundbreaking research and development efforts. Her dedication to innovation in pharmaceuticals is evident through her successful patent applications and ongoing research.

Collaborations

Delacruz has worked alongside notable colleagues such as Christina Capacci-Daniel and Baoqing Gong. These collaborations have fostered a dynamic environment for innovation and have enhanced the quality of research conducted at Novartis AG.

Conclusion

Marilyn Delacruz's contributions to the field of pharmaceuticals through her patents and collaborations highlight her role as a key innovator. Her work continues to inspire advancements in medical treatments, showcasing the importance of innovation in improving healthcare outcomes.